Meet the 360biolabs team

360biolabs has a team of world class biologists and chemists with pharma and biotech industry experience and a proven track record of advancing therapeutic drugs, biomolecules and vaccines through clinical development. 360biolabs has the technical knowledge and experience to deliver accurate, reproducible and robust assay data which will progress your therapeutic through regulatory review. We are dedicated to providing a quality service that efficiently delivers your data and are proud of our reputation as a highly skilled team with a flexible and responsive approach to study management and communication.

We are passionate about ensuring our work adds value to our clients’ products.

(From image left to right.)

Melinda Pryor PhD – Executive Vice President, Clinical

Co-founder with a wealth of experience in the design and implementation of large multi-centre international clinical trials. Melinda has more than 25 years’ experience in molecular virology and immunology and leads our high performing clinical team. Melinda is focussed on delivering regulatory compliant data and providing expert clinical support to our clients.

Angela Luttick – Executive Vice President, Business Development

Co-founder and Executive Director, Angela leads business development and future expansion activities. Angela has extensive drug discovery pharmaceutical experience and expertise in early phase drug discovery through to IND filing. With a background in virology and the combination of technical expertise and business acumen, Angela understands a client’s requirements from the initial engagement.

Alistair Draffan PhD – Chief Executive Officer

Co-founder with more than 20 years’ industry experience in collaborative pharmaceutical R&D and management. Alistair has a background in medicinal chemistry and a track record of leading teams that have successfully translated drug candidates into the clinic. Alistair ensures operational and quality management system best practice is applied to all studies we support.